Investment Focus: Healthcare
Coco Zhang is an Investment Director at Co-win Ventures.
Coco joined Co-win Ventures in 2017. Her career in venture capital started in 2014. Prior to Co-win Ventures, she was an associate of Everest Venture Capital and an industry researcher in Grains Valley Venture Capital. Coco has led and participated in deals such as Ascentage Pharma (06855.HK), HaploX, Kidney Health, Immorna Therapeutics，Neologics Bioscience，InsureSmart，TiaoDing technology.
Coco Zhang holds an MS in Physiology and a BS in Basic Medical Science from Peking University Health Science Center.